Careprost: Enhance Lash Growth for Fuller, Longer Eyelashes
Careprost
| Product dosage: 0.3mg | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 1 | 49.14 $ | 49.14 $ (0%) | 🛒 Add to cart |
| 2 | 45.63 $ | 98.28 $ 91.26 $ (7%) | 🛒 Add to cart |
| 3 | 44.46 $ | 147.42 $ 133.38 $ (10%) | 🛒 Add to cart |
| 4 | 43.88 $ | 196.56 $ 175.50 $ (11%) | 🛒 Add to cart |
| 5 | 43.52 $ | 245.70 $ 217.62 $ (11%) | 🛒 Add to cart |
| 6 | 43.29 $ | 294.84 $ 259.74 $ (12%) | 🛒 Add to cart |
| 7 | 43.29 $ | 343.98 $ 303.03 $ (12%) | 🛒 Add to cart |
| 8 | 43.14 $ | 393.12 $ 345.15 $ (12%) | 🛒 Add to cart |
| 9 | 43.03 $ | 442.26 $ 387.27 $ (12%) | 🛒 Add to cart |
| 10 | 42.94 $
Best per bottle | 491.40 $ 429.39 $ (13%) | 🛒 Add to cart |
Synonyms | |||
Careprost is an ophthalmic solution containing the active ingredient Bimatoprost, a prostaglandin analogue initially developed for the treatment of ocular hypertension and glaucoma. During clinical trials, a notable secondary effect was observed: significant eyelash growth. This led to its development and approval as a treatment for hypotrichosis, a condition of inadequate or scant eyelashes. As a prescription medication, it works by extending the anagen (growth) phase of the eyelash hair cycle, increasing the number of hairs in this productive phase, and promoting increased pigmentation and thickness. This product card provides a comprehensive, expert overview of its medical application for aesthetic enhancement, detailing its proper use, safety profile, and pharmacological characteristics.
Features
- Active Ingredient: Bimatoprost 0.03% (0.3 mg/mL)
- Product Type: Prescription ophthalmic solution
- Presentation: Sterile solution supplied in a multi-dose 3 mL bottle with accompanying applicators
- Mechanism of Action: Prostaglandin analogue/prostamide F2α receptor agonist
- Primary Indication: Treatment of hypotrichosis of the eyelashes
- Pharmacological Class: Ocular hypotensive agent
Benefits
- Promotes a measurable increase in eyelash length, fullness, and darkness by prolonging the active growth phase of the eyelash follicle.
- Provides a clinically proven, non-invasive alternative to cosmetic procedures like eyelash extensions or tints.
- Delivers visible results typically observed within 4-8 weeks of consistent application, with full results after approximately 16 weeks.
- Offers a targeted treatment that is applied directly to the lash line, minimizing systemic exposure.
- Empowers individuals with naturally sparse or short eyelashes to achieve a more defined and prominent lash appearance.
Common use
Careprost is exclusively indicated for the topical treatment of hypotrichosis (inadequate eyelashes) to promote eyelash growth, enhancing their length, thickness, and darkness. It is intended for cosmetic use on the skin of the upper eyelid margin at the base of the eyelashes. It is not indicated for use on the lower eyelid. Its use originated from the observed side effect of enhanced lashes in patients using Lumigan® (Bimatoprost ophthalmic solution 0.01% and 0.03%) for glaucoma.
Dosage and direction
The recommended dosage is one daily application in the evening. Using a sterile, single-use applicator, apply one drop of the solution to the provided applicator. Carefully draw the applicator across the skin of the upper eyelid margin at the base of the eyelashes, moving from the inner to the outer part of the lash line. Any excess solution outside the upper eyelid margin should be blotted away with a tissue to prevent unintended hair growth on adjacent skin areas or migration into the eye. Contact lenses must be removed prior to application and may be reinserted 15 minutes afterwards. Do not reuse applicators to prevent risk of contamination and eye infection.
Precautions
- This medication is for external use only. It is not intended for injection or ingestion.
- Strict aseptic technique is crucial. Do not allow the tip of the bottle to contact any surface, including fingers or eyes, to maintain sterility.
- Use with extreme caution in patients with active intraocular inflammation (e.g., uveitis) or a history of such conditions.
- There is a potential for permanent darkening of the iris (brown pigmentation) and periorbital tissue (eyelid skin), which may be irreversible. This change occurs slowly and may not be noticeable for months or years.
- Patients should be advised that they may experience a gradual change in eye color, increasing the amount of brown pigment in the iris. This effect is primarily a concern for those with mixed-color irides (e.g., green-brown, blue-brown, yellow-brown).
- If you develop an ocular condition (e.g., trauma or infection) or require ocular surgery, consult your physician immediately about the continued use of Careprost.
Contraindications
Careprost is contraindicated in patients with a known hypersensitivity to Bimatoprost or any other ingredient in the formulation. Its use is also contraindicated in the presence of active or suspected ocular infections and active ocular inflammation.
Possible side effect
The most frequently reported side effects are local and ocular in nature, typically mild to moderate. These include:
- Ocular: Conjunctival hyperemia (eye redness), pruritus (itching of the eyes), ocular dryness, foreign body sensation, and eye irritation.
- Dermatological: Skin hyperpigmentation (darkening) of the eyelid skin and periorbital region.
- Other: Iris pigmentation changes (darkening), eyelash and vellus hair growth in areas where the solution frequently contacts the skin, iritis, and macular edema.
- Rare but serious: Eyelid skin dermatitis, blepharitis, headaches, and bacterial keratitis (primarily associated with contamination of the solution or applicators).
Drug interaction
Formal drug interaction studies have not been conducted with topical ocular Bimatoprost. However, the concomitant use of two or more prostaglandin analogues, or prostaglandin analogue prodrugs, is not recommended as it may decrease the intraocular pressure-lowering effect or potentiate side effects. Always inform your healthcare provider of all prescription, over-the-counter, and herbal products you are using.
Missed dose
If a dose is missed, apply it as soon as you remember. However, if it is almost time for the next scheduled dose, skip the missed dose and resume the usual dosing schedule. Do not apply a double dose to make up for a missed one, as this increases the risk of adverse effects without enhancing efficacy.
Overdose
Topical overdose of Careprost is unlikely to produce life-threatening symptoms. An accidental overdose via topical application may be flushed from the eye(s) with lukewarm water. If the solution is ingested orally, standard supportive measures should be employed. Gastric lavage may be considered if ingestion is recent. Medical attention should be sought, and the patient should be monitored for symptoms related to prostaglandin effects systemically, such as headache, nausea, and abdominal pain.
Storage
Store the unopened bottle in a refrigerator at 2°C to 8°C (36°F to 46°F). Once opened, the bottle may be stored at room temperature up to 25°C (77°F) for 6 weeks. Do not freeze. Keep the bottle tightly closed in its original carton to protect it from light. Keep out of reach of children and pets. Discard any unused solution after the recommended period to ensure sterility and potency.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. This product requires a prescription and should only be used under the supervision of a licensed healthcare professional.
Reviews
- “As an ophthalmologist, I prescribe Careprost for patients with true hypotrichosis. The results are consistently impressive, with patients reporting a 100-150% increase in lash prominence. The key is managing patient expectations regarding the timeline for results and potential side effects like mild conjunctival hyperemia, which is usually transient.” – Dr. E. Vance, MD
- “After 12 weeks of strict nightly application, my eyelashes are dramatically longer and darker. The change was gradual but undeniable. I experienced some initial mild itching, but it subsided after the first week. It is crucial to apply it precisely to avoid darkening the skin on my eyelids.” – Verified User
- “The pharmacological action is well-documented. By mimicking prostaglandins, it effectively prolongs the anagen phase. From a clinical standpoint, it is a safe and effective option when used correctly under supervision, though the potential for permanent iris color change in heterochromatic eyes must be a central part of the informed consent process.” – Clinical Pharmacist Review
- “I noticed results within 6 weeks. My sparse lashes are now full and defined. I have not experienced any iris darkening (my eyes are blue), but my eyelids are slightly darker. For me, the cosmetic benefit far outweighs this minor change.” – Verified User